Name | N-Hydroxy-N2-[(4-methoxyphenyl)sulfonyl]-N2-(3-pyridinylmethyl)-D-valinamide hydrochloride (1:1) |
---|---|
Synonyms |
N-Hydroxy-N2-[(4-methoxyphenyl)sulfonyl]-N2-(3-pyridinylmethyl)-D-valinamide hydrochloride (1:1)
Butanamide, N-hydroxy-2-[[(4-methoxyphenyl)sulfonyl](3-pyridinylmethyl)amino]-3-methyl-, (2R)-, hydrochloride (1:1) |
Description | CGS 27023A (MMI 270) is a potent, orally active MMP inhibitor with Ki of 8-43 nM for MMP1/2/3/9. |
---|---|
In Vitro | CGS 27023A (MMI 270) is a potent, orally active MMP inhibitor with Ki of 8-43 nM for MMP1/2/3/9; shows growth-inhibitory effects in breast carcinoma, prostate, bladder, colon, lung adenocarcinoma, glioblastoma, and ovarian carcinoma cell line;.protects the cartilage proteoglycan matrix in a partial meniscectomy model of osteoarthritis in rabbits.Solid TumorsPhase 2 Discontinued |
Molecular Formula | C18H24ClN3O5S |
---|---|
Molecular Weight | 429.918 |
Exact Mass | 429.112518 |